Modulating osteoclasts with nanoparticles: A path for osteoporosis management?
Loading...
Identifiers
Publication date
Advisors
Tutors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Wiley
Abstract
Osteoclasts are the cells responsible for the bone resorption process during bone
remodeling. In a healthy situation, this process results from an equilibrium
between new matrix formation by osteoblast and matrix resorption by osteoclast.
Osteoporosis (OP) is a systemic bone disease characterized by a decreased bone
mass density and alterations in bone microarchitecture, increasing fracture pre disposition. Despite the variety of available therapies for OP management there is
a growing gap in its treatment associated to the low patients´ adherence owing to
concerns related with long-term efficacy or safety. This makes the development
of new and safe treatments necessary. Among the newly developed strategies, the
use of synthetic and natural nanoparticles to modulate osteoclasts differentiation,
activity, apoptosis or crosstalk with osteoblasts have arisen. Synthetic
nanoparticles exert their therapeutic effect either by loading antiresorptive drugs
or including molecules for osteoclasts gene regulation. Moreover, this control
over osteoclasts can be improved by their targeting to bone extracellular matrix
or osteoclast membranes. Furthermore, natural nanoparticles, also known as
extracellular vesicles, have been identified to play a key role in bone homeostasis.
Consequently, these systems have been widely studied to control osteoblasts and
osteoclasts under variable environments. Additionally, the ability to bioengineer
extracellular vesicles has allowed to obtain biomimetic systems with desirable
characteristics as drug carriers for osteoclasts. The analyzed information reveals
the possibility of modulating osteoclasts by different mechanisms through nanoparticles decreasing bone resorption. These findings suggest that controlling
osteoclast activity using nanoparticles has the potential to improve osteoporosis
management. This article is categorized under: Implantable Materials and Surgical Technologies > Nanomaterials and Implants Implantable Materials and Surgical Technologies > Nanotechnology in Tissue Repair and Replacement Nanotechnology Approaches to Biology > Nanoscale Systems in Biology
Description
Bibliographic citation
Rouco, H., García-García, P., Briffault, E., & Diaz-Rodriguez, P. (2023). Modulating osteoclasts with nanoparticles: A path for osteoporosis management? WIREs Nanomedicine and Nanobiotechnology, e1885. https://doi.org/10.1002/wnan.1885
Relation
Has part
Has version
Is based on
Is part of
Is referenced by
Is version of
Requires
Publisher version
https://doi.org/10.1002/wnan.1885Sponsors
Patricia García-García acknowledges the University of La Laguna for the action “Recualificación de personal universitario: Margarita Salas para la formación de jóvenes doctores”. Helena Rouco acknowledges the University of Santiago de Compostela for the action “Recualificación de personal universitario: Margarita Salas para la formación de jóvenes doctores”. This work was funded by MCIN/AEI/10.13039/501100011033/FEDER, UE, (PID2021-127493OA-C22)
Rights
© 2023 The Authors. WIREs Nanomedicine and Nanobiotechnology published by Wiley Periodicals LLC. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited
Atribución 4.0 Internacional
Atribución 4.0 Internacional








